3Indexed trials
drug · Product Intelligence
Atosiban
Pipeline Intelligence
Atosiban: 3 indexed trials, 2 sponsors; 0 linked Orange Book patents and 0 FDA-linked events where matched.
2Sponsors
0Orange Book patent links
0FDA-linked events
Development evidence
NCT02292784GlaxoSmithKline · out_of_scopePHASE3
NCT07093060University of Electronic Science and Technology of China · out_of_scopeEARLY_PHASE1
NCT07140237University of Electronic Science and Technology of China · out_of_scopeEARLY_PHASE1
FDA / patent evidence
No FDA Orange Book product match is asserted for this intervention.
Regulatory context
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.